ClinicalTrials.govpublic full text
Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19
sars-cov2 infection, monoamine oxidase inhibitor, activation phenotype of t and myeloid cells, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803528
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.